HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
January 14, 2025
Host Jonathan Miller interviews CEO:John Lai. He describes how PetVivo provides the best standards for Pets in medicine.